Tushar Tewari

Sep 27, 2018
India has long been a leader in developing safe, effective, and affordable vaccines for the global market, so it should really come as no surprise that, for the second time this year, the World Health Organization (WHO) has prequalified a new
Sep 26, 2017
As results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd. (SIIPL)’s rotavirus vaccine BRV-PV (now known as ROTASIIL) are published in the journal Vaccine, I find myself reflecting on the great partnership that